Orlando Clinical Research Center OCRC

Orlando, Florida 32809-3017

1 studies enrolling now · 20 studies all time

What they study most

Bacterial Infections, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Digestive System Diseases, Healthy, Healthy Volunteers, Hepatic Impairment, Hepatic Insufficiency, Impaired Renal Function, Liver Diseases, Moderate Hepatic Impairment, Renal Impairment

Studies at this site

• Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency — Recruiting now
• Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment — Completed
• A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment — Completed
• A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function — Completed
• A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment — Completed
• Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment — Completed
• A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function — Completed
• A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment — Completed
• To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females. — Completed
• Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function — Completed
• A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod — Completed
• Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment — Completed
• Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function — Completed
• Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function — Completed
• Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy Subjects — Completed
• A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects — Completed
• A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment. — Completed
• Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort — Completed
• A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment — Completed
• Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy — Completed